Long-Term Results for Uterine-Sparing Fibroid Care
Long Term Effectiveness of Uterine Sparing Fibroid Treatments
This project aims to understand the long-term health and quality of life for women who have received treatments for uterine fibroids that allow them to keep their uterus.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry Ford Health System NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-11158658 on NIH RePORTER |
What this research studies
Uterine fibroids are very common, especially among Black women, and often lead to hysterectomies, causing heavy bleeding, pain, and other issues. While there are several options to treat fibroids without removing the uterus, like myomectomy or uterine artery embolization, we don't have enough information about how well these treatments work over many years. This project will follow women who have already had these uterine-sparing treatments for up to 10 years, gathering important details about their symptoms, quality of life, and any further treatments needed. The goal is to provide better guidance for women and their doctors when choosing the best fibroid treatment.
Who could benefit from this research
Good fit: This project is for women who have previously participated in the COMPARE-UF or ULTRA registries and have undergone uterine-sparing fibroid treatments.
Not a fit: Patients who have not had uterine fibroids or who have not received uterine-sparing treatments would not directly benefit from this specific follow-up project.
Why it matters
Potential benefit: If successful, this work could help women and their doctors make more informed decisions about uterine fibroid treatments, potentially improving long-term health outcomes and quality of life.
How similar studies have performed: Prior studies on uterine fibroid treatments have had limited follow-up time, making this project novel in its focus on long-term outcomes.
Where this research is happening
Detroit, United States
- Henry Ford Health System — Detroit, United States (Active)
Researchers
- Principal investigator: Wegienka, Ganesa Rebecca — Henry Ford Health System
- Study coordinator: Wegienka, Ganesa Rebecca
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.